Nitrofurantoin Pulmonary Toxicity: A Brief Review

Author(s): Bobbak Vahid, Bernadette M.M. Wildemore

Journal Name: Current Respiratory Medicine Reviews

Volume 2 , Issue 4 , 2006

Become EABM
Become Reviewer
Call for Editor


Nitrofurantoin is an antimicrobial agent that is commonly used for the treatment of recurrent urinary tract infection. Nitrofurantoin pulmonary toxicity can present as acute, subacute, or chronic respiratory disease. Common manifestations are dry cough, chest pain, dyspnea, and hypoxemia. Skin rash, arthralgia, and abnormal transaminases are occasionally present. Chest imaging shows patchy infiltrates and fibrosis. Treatment includes discontinuing the medication. Although the role of corticosteroids has not been well described, patients with respiratory symptoms or hypoxemia may benefit from a trial of corticosteroid therapy.

Keywords: Nitrofurantoin, drug-induced lung toxicity, organizing pneumonia, pneumonitis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [439 - 442]
Pages: 4
DOI: 10.2174/157339806778777276
Price: $65

Article Metrics

PDF: 3